Work

Longitudinal tumor-informed ctDNA monitoring and clinical outcomes in advanced urothelial carcinoma treated with enfortumab vedotin ± pembrolizumab.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4569

Authors: Adanma Ayanambakkam, Kevin R. Reyes, Ryan Zhu, Cameron Herberts, Punashi Dutta, Ashley Wray, Beaux Mitchell, Syed Saqib Balkhi, Xiaolin Zhu, Carissa E. Chu, Sima P. Porten, Terence W. Friedlander, Jonathan Chou, Steven Neema Seyedin, Shruti Sharma, Meenakshi Malhotra, Minetta C. Liu, Adam ElNaggar, Vadim S. Koshkin

Institutions: OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, University of Oklahoma, University of California, San Francisco

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162503791

Cites:

Cited by: 1

Related to: